Background
==========

Pancreatic cancer (PC) is the fourth leading cause of cancer death in the United States and has no cure, partly because the tumor is at advanced stage or has already metastasized at the time of diagnosis \[[@B1]\]. Like many other types of cancer, pancreatic cancer also shows high frequencies of overexpression and/or amplification of the c-*myc*oncogene. In one study, 43.5% of primary tumors and 31.6% of metastases showed c-Myc overexpression, in association with 32.5% and 29.4% of gene amplification in the primary and metastatic lesions, respectively \[[@B2]\]. c-Myc and cyclin D1 gene amplification was report 54% and 28% in 31 pancreatic cancer cell lines, respectively, indicating a high frequency of concomitant amplification of both genes \[[@B3]\]. Moreover, simultaneous amplification of activated k-*ras*and c-*myc*has been found in both primary tumor and lymph node metastasis, suggesting that c-Myc may collaborate with other oncogenes to promote development and progression of pancreatic cancer \[[@B4]\]. More direct evidence for a critical role for c-Myc in pancreatic carcinogenesis comes from Ela-c-*myc*transgenic mice that develop PC between 2--7 months of age with 100% incidence rate \[[@B5]\]. One-half of the pancreatic tumors that form in this mouse model are acinar cell adenocarcinomas, while the remaining half of the tumors are mixed ductal and acinar cell carcinomas embedded in dense stroma. We have recently described detailed morphological traits of the pancreatic tumors developed in this transgenic model \[[@B6],[@B7]\] and, for the first time, observed spontaneous metastasis to the liver in this model. These transgenic mice are among the few animal models of liver metastasis of spontaneous PC. The whole carcinogenic process, from initiation to metastasis, is short (in only a few months time) and is initiated by only one gene.

The most devastating aspect of all types of cancer, particularly pancreatic cancer, is the emergence of metastases in organs distant from the primary tumor, and this remains the primary cause for the poor survival of patients with pancreatic cancer \[[@B8]\]. Therefore, a search for molecular markers that can predict poor prognosis and also serve as novel targets for the development of therapies against this most aggressive disease is warranted. Transgenic animals have been widely used to dissect the role of genes and molecular pathways in cancer \[[@B9]\]. Our transgenic model will help in understanding the molecular mechanisms by which metastases are generated, which is crucial for the prevention and treatment of metastatic disease. In this study we attempted to identify genes that may be responsible for the liver metastasis of pancreatic tumors in Ela-*myc*transgenic mice.

Results
=======

cDNA Microarray Analysis and Global Gene Expression Profiles
------------------------------------------------------------

Microarray signal values were calculated from the multiple probes present on each chip for each condition and each condition was repeated at least three times. The relative intensity (fold change) of gene expression levels in the primary tumors (PT) compared to the normal pancreas (NP) is shown in Figure [1A](#F1){ref-type="fig"} (left panel) and fold change in gene expression in liver metastatic (LM) lesions compared to PT are presented in Figures [1A](#F1){ref-type="fig"} (right panel).

![**Gene expression profiles**. **A)**Histogram showing a similar (left) and differential (right) gene expression profiles of primary pancreatic tumors and liver metastatic lesions from Ela-*c-Myc*transgenic mice compared to normal pancreas from wild type littermates. **B)**Hierarchical clustering of differentially expressed genes. Clustering tree illustrate the expression pattern and similarity in primary pancreatic tumors (labeled as PT) and liver metastatic lesions (labeled as LM) compared to normal pancreas (labeled as NP) indicated by color bars. **C)**Shows only the differentially expressed gene profile with at least a four-fold change (≤4 or ≥4) indicated by color bars. (blue-down regulated and red up-regulated).](1476-4598-7-11-1){#F1}

Cluster analysis was used to display the gene expression data of those, which showed 4-fold higher or 4-fold lower expression levels in PT and LM compared to NP samples. Before clustering, a filtering procedure eliminated genes with uniformly low expression or with low expression variation across the replicates. A large number of genes in PT and LM showed different expression from NP. However, the majority of genes did not show obvious distinction in their expression pattern between the PT and LM (Fig. [1B](#F1){ref-type="fig"}), except for a small number of genes (boxed area in Fig. [1B](#F1){ref-type="fig"} expanded in Fig. [1C](#F1){ref-type="fig"}), suggesting that the LM largely retain the properties of the primary tumors.

Identification of potential tumor promoting genes in c-myc-induced pancreatic tumors
------------------------------------------------------------------------------------

Expressed genes were categorized on the basis of their functional properties, which showed at least 4-fold higher, or 4-fold lower expression levels in primary or metastatic pancreatic tumors compared to normal pancreas. Table [1](#T1){ref-type="table"} shows genes whose expression was upregulated in PT compared to NP (relative fold change) and also shows the relative fold change in LM compared to PT samples. Many upregulated genes such as Birc5, Ccna2, Ccnb1, Ccnb2, Mcm7, Nap1l1, Rad51, Smc4l1, Smc2l1, Rsk4, sfrs1, and sfrs2 (please see Table [1](#T1){ref-type="table"} for their full names) showed 5--20 fold higher expression levels, very few showed exceptionally high fold changes, for example calcium binding protein-S100g showed 109 fold higher expression level in PT than in NP. A large number of upregulated genes in PT belonged to the functional categories known for cell proliferation and cell cycle regulation, chromosomal organization and biogenesis, and RNA processing and modification. In Table [2](#T2){ref-type="table"}, we show the genes whose expression was down regulated in PT compared to NP samples (relative fold change) as well as the fold change in LM compared to PT samples. Down regulation of some of the genes in Table [2](#T2){ref-type="table"} including Col4a4, Pcdh17, Muc2, Muc13 (please see Table [2](#T2){ref-type="table"} for their full names) has been shown to modulate cell adhesion and apoptosis.

###### 

Upregulated genes in primary pancreatic tumors. Relative fold change in primary pancreatic tumors compared to normal pancreas (PT/NP) and in liver metastatic lesions compared to primary pancreatic tumors (LM/PT).

  **Entrez Gene**                                                  **Fold change LM\*/PT\***   **Fold change PT/NP\***   **Gene Symbol**   **Gene description**                                    **Ref.\***
  ---------------------------------------------------------------- --------------------------- ------------------------- ----------------- ------------------------------------------------------- ------------
  **Mitochondrial ribosomal subunits**                                                                                                                                                             
  **77721**                                                        1.0                         4.2                       Mrps5             Mitochondrial ribosomal protein S5                      
  **69527**                                                        1.0                         4.5                       Mrps9             Mitochondrial ribosomal protein S9                      
  **94063**                                                        1.0                         4.1                       Mrpl16            Mitochondrial ribosomal protein L16                     
  **56284**                                                        0.9                         5.0                       Mrpl19            Mitochondrial ribosomal protein L19                     
  **66407**                                                        0.8                         4.1                       Mrps15            Mitochondrial ribosomal protein S15                     
  **64655**                                                        1.2                         7.6                       Mrps22            Mitochondrial ribosomal protein S22                     
  **64658**                                                        1.0                         4.1                       Mrps25            Mitochondrial ribosomal protein S25                     
  **Nucleolar and nucleosome assembly proteins**                                                                                                                                                   
  **53605**                                                        0.9                         13.5                      Nap1l1            Nucleosome assembly protein 1-like 1                    **10, 11**
  **110109**                                                       0.9                         4.3                       Nol1              Nucleolar protein 1                                     
  **52530**                                                        1.0                         10.0                      Nola2             Nucleolar protein family A, member 2                    
  **100608**                                                       1.1                         9.4                       Noc4l             Nucleolar complex associated 4 homolog                  
  **55989**                                                        0.8                         6.3                       Nol5              Nucleolar protein 5                                     
  **67134**                                                        0.9                         7.8                       Nol5a             Nucleolar protein 5A                                    
  **Small nuclear ribonucleoprotein complex**                                                                                                                                                      
  **68981**                                                        1.1                         8.7                       Snrpa1            Small nuclear ribonucleoprotein polypeptide A\'         
  **20638**                                                        0.9                         8.3                       Snrpb             Small nuclear ribonucleoprotein B                       
  **20641**                                                        1.1                         7.1                       Snrpd1            Small nuclear ribonucleoprotein D1                      
  **67332**                                                        1.1                         7.4                       Snrpd3            Small nuclear ribonucleoprotein D3                      
  **69878**                                                        1.1                         6.9                       Snrpf             Small nuclear ribonucleoprotein polypeptide F           
  **666609**                                                       1.0                         7.6                       Snrpg             small nuclear ribonucleoprotein polypeptide G           
  **Splicing factor**                                                                                                                                                                              
  **110809**                                                       1.1                         5.5                       Sfrs1             Splicing factor, arginine/serine-rich 1 (ASF/SF2)       
  **20382**                                                        1.1                         5.1                       Sfrs2             Splicing factor, arginine/serine-rich 2 (SC-35)         
  **20383**                                                        1.1                         5.0                       Sfrs3             Splicing factor, arginine/serine-rich 3 (SRp20)         
  **81898**                                                        1.2                         5.2                       Sf3b1             Splicing factor 3b, subunit 1                           **15**
  **66125**                                                        1.2                         8.0                       Sf3b5             Splicing factor 3b, subunit 5                           **15**
  **225027**                                                       1.2                         4.1                       Sfrs7             Splicing factor, arginine/serine-rich 7                 
  **RNA binding and pre-mRNA processing factors**                                                                                                                                                  
  **28000**                                                        1.1                         4.7                       Prpf19            PRP19/PSO4 pre-mRNA processing factor 19 homolog        
  **68988**                                                        1.1                         5.0                       Prpf31            PRP31 pre-mRNA processing factor 31 homolog (yeast)     
  **56194**                                                        1.1                         5.8                       Prpf40a           PRP40 pre-mRNA processing factor 40 homolog A (yeast)   
  **56275**                                                        0.9                         5.5                       Rbm14             RNA binding motif protein 14                            
  **67071**                                                        1.0                         16.2                      Rps6ka6 (Rsk4)    Ribosomal protein S6 kinase polypeptide 6               
  **Spliceosome complex**                                                                                                                                                                          
  **81898**                                                        1.2                         5.2                       Sf3b1             Splicing factor 3b, subunit 1                           **15**
  **66125**                                                        1.2                         8.0                       Sf3b5             Splicing factor 3b, subunit 5                           **15**
  **20382**                                                        1.1                         4.9                       Sfrs2             Splicing factor, arginine/serine-rich 2 (SC-35)         
  **68981**                                                        1.1                         8.7                       Snrpa1            Small nuclear ribonucleoprotein polypeptide A\'         
  **20638**                                                        0.9                         8.3                       Snrpb             Small nuclear ribonucleoprotein B                       
  **20641**                                                        1.1                         7.1                       Snrpd1            Small nuclear ribonucleoprotein D1                      
  **69878**                                                        1.1                         6.9                       Snrpf             Small nuclear ribonucleoprotein polypeptide F           
  **666609**                                                       1.0                         7.6                       Snrpg             small nuclear ribonucleoprotein polypeptide G           
  **Cell proliferation and cell cycle regulation related genes**                                                                                                                                   
  **12428**                                                        1.0                         16.6                      Ccna2             Cyclin A2                                               
  **268697**                                                       1.2                         11.2                      Ccnb1             Cyclin B1                                               
  **12429**                                                        1.1                         17.9                      Ccnb1-rs1         Cyclin B1, related sequence 1                           
  **12442**                                                        0.9                         17.8                      Ccnb2             Cyclin B2                                               **15, 25**
  **12448**                                                        1.3                         4.9                       Ccne2             Cyclin E2                                               
  **12449**                                                        0.9                         8.9                       Ccnf              Cyclin F                                                
  **17216**                                                        0.9                         9.0                       Mcm2              Minichromosome maintenance deficient 2                  **14**
  **17215**                                                        0.9                         8.6                       Mcm3              Minichromosome maintenance deficient 3                  
  **17217**                                                        1.2                         8.6                       Mcm4              Minichromosome maintenance deficient 4                  **10**
  **17218**                                                        1.0                         11.8                      Mcm5              Minichromosome maintenance deficient 5                  
  **17219**                                                        1.1                         20.1                      Mcm6              Minichromosome maintenance deficient 6                  
  **17220**                                                        0.9                         11.0                      Mcm7              Minichromosome maintenance deficient 7                  **14**
  **70024**                                                        1.1                         6.3                       Mcm10             Minichromosome maintenance deficient 10                 
  **11799**                                                        1.0                         11.1                      Birc5             Baculoviral IAP repeat-containing 5                     
  **12211**                                                        1.0                         4.4                       Birc6             Baculoviral IAP repeat-containing 6                     
  **12189**                                                        1.0                         5.5                       Brca1             Breast cancer 1                                         
  **70099**                                                        0.9                         17.3                      Smc4l1            Structural maintenance of chromosomes 4                 
  **19361**                                                        1.0                         15.1                      Rad51             RAD51 homolog (S. cerevisiae)                           
  **Cell adhesion and migration**                                                                                                                                                                  
  **12774**                                                        1.1                         6.7                       Ccr5              Chemokine (C-C motif) receptor 5                        
  **56492**                                                        1.4                         6.6                       Cldn18            Claudin 18                                              25
  **Cell communication and signal trasduction**                                                                                                                                                    
  **75590**                                                        0.8                         30.3                      Dusp9             Dual specificity phosphatase 9                          
  **67071**                                                        1.0                         16.2                      Rps6ka6 (Rsk4)    Ribosomal protein S6 kinase polypeptide 6               
  **12774**                                                        1.1                         6.7                       Ccr5              Chemokine (C-C motif) receptor 5                        
  **56275**                                                        0.9                         5.5                       Rbm14             RNA binding motif protein 14                            
  **12309**                                                        0.7                         109.4                     S100g             S100 calcium binding protein G                          **10, 25**
  **Apoptosis regulation related**                                                                                                                                                                 
  **11799**                                                        1.0                         11.1                      Birc5             Baculoviral IAP repeat-containing 5                     **16**
  **17218**                                                        1.0                         11.8                      Mcm5              Minichromosome maintenance deficient 5,                 
  **17319**                                                        1.1                         6.8                       Mif               Macrophage migration inhibitory factor                  
  **Chromosome organization and biogenesis**                                                                                                                                                       
  **14211**                                                        1.1                         12.7                      Smc2l1            Structural maintenance of chromosomes 2                 
  **70099**                                                        0.9                         17.3                      Smc4l1            Structural maintenance of chromosomes 4                 
  **226026**                                                       1.0                         5.4                       Smc5l1            Structural maintenance of chromosomes 5                 
  **19361**                                                        1.0                         15.1                      Rad51             RAD51 homolog (S. cerevisiae)                           **12**
  **12189**                                                        1.0                         5.5                       Brca1             Breast cancer 1                                         
  **53605**                                                        0.9                         13.5                      Nap1l1            Nucleosome assembly protein 1-like 1                    **10, 11**
  **17216**                                                        0.9                         9.0                       Mcm2              Minichromosome maintenance deficient 2 mitotin          
  **17218**                                                        1.0                         11.8                      Mcm5              Minichromosome maintenance deficient 5                  
  **Transcriptional regulator**                                                                                                                                                                    
  **22431**                                                        0.6                         2.7                       Wt1               Wilms\' tumor suppressor gene                           **57**

**NP = Normal pancreas; PT = Primary pancreatic tumor; LM = liver metastatic lesion; Ref**.\* = References identifying genes previously shown to have deregulated expression in pancreatic cancer

###### 

Downregulated genes in primary pancreatic tumors. Relative fold change in primary pancreatic tumors compared to normal pancreas (PT/NP) and in liver metastatic lesions compared to primary pancreatic tumors (LM/PT)

  **Entrez Gene\#**                               **Fold change LM/PT**   **Fold change PT/NP**   **Gene Symbol**   **Gene description**                                      **Ref.\***
  ----------------------------------------------- ----------------------- ----------------------- ----------------- --------------------------------------------------------- ------------
  **Cell adhesion, motility and migration**                                                                                                                                   
  **12340**                                       0.84                    -11.6                   Capza1            Capping protein (actin filament) muscle Z-line, alpha 1   **16**
  **12829**                                       0.98                    -10.8                   Col4a4            Procollagen, type IV, alpha 4                             
  **13643**                                       1.02                    -7.6                    Efnb3             Ephrin B3                                                 
  **215384**                                      1.03                    -8                      Fcgbp             Fc fragment of IgG binding protein                        
  **16855**                                       1.00                    -6.4                    Lgals4            Lectin, galactose binding, soluble 4                      
  **17831**                                       1.02                    -40                     Muc2              Mucin 2                                                   
  **219228**                                      1.51                    -18.8                   Pcdh17            Protocadherin 17                                          
  **68799**                                       1.20                    -7.2                    Rgmb              RGM domain family, member B                               
  **16855**                                       1.00                    -6.4                    Lgals4            Lectin, galactose binding, soluble 4                      
  **Cell communication and signal trasduction**                                                                                                                               
  **12154**                                       1.09                    -4                      Bmp10             Bone morphogenetic protein 10                             
  **13643**                                       1.02                    -7.6                    Efnb3             Ephrin B3                                                 
  **14463**                                       1.01                    -8                      Gata4             GATA binding protein 4                                    
  **15874**                                       0.96                    -40                     Iapp              Islet amyloid polypeptide                                 
  **16333**                                       0.85                    -23.2                   Ins1              Insulin I                                                 
  **14526**                                       0.91                    -21.6                   Gcg               Glucagon                                                  
  **70497**                                       0.86                    -8                      Arhgap17          Rho GTPase activating protein 17                          
  **232201**                                      0.83                    -7.6                    Arhgap25          Rho GTPase activating protein 25                          
  **110052**                                      1.00                    -8.4                    Dek               DEK oncogene (DNA binding)                                **16**
  **14915**                                       0.98                    -13.6                   Guca2a            Guanylate cyclase activator 2a (guanylin)                 
  **212307**                                      0.81                    -7.2                    Mapre2            Microtubule-associated protein, RP/EB family, member 2    
  **20844**                                       1.15                    -13.6                   Stam              Signal transducing adaptor molecule                       
  **66042**                                       0.85                    -14.8                   Sostdc1           Sclerostin domain containing 1                            
  **68799**                                       1.20                    -7.2                    Rgmb              RGM domain family, member B                               
  **80718**                                       0.91                    -6.4                    Rab27b            RAB27b, member RAS oncogene family                        
  **18386**                                       0.93                    -6                      Oprd1             Opioid receptor, delta 1                                  
  **67709**                                       0.88                    -13.6                   Reg4              Regenerating islet-derived family, member 4               
  **Cell cycle and cell proliferation**                                                                                                                                       
  **76499**                                       1.02                    -8.8                    Clasp2            CLIP associating protein 2                                
  **16333**                                       0.85                    -23.2                   Ins1              Insulin I                                                 
  **16334**                                       0.98                    -40                     Ins2              Insulin II                                                
  **212307**                                      0.81                    -7.2                    Mapre2            Microtubule-associated protein, RP/EB family, member 2    
  **22268**                                       0.90                    -6                      Upk1b             Uroplakin 1B                                              
  **14526**                                       0.91                    -21.6                   Gcg               Glucagon                                                  
  **212307**                                      0.81                    -7.2                    Mapre2            Microtubule-associated protein, RP/EB family, member 2    
  **57263**                                       1.11                    -28                     Retnlb            Resistin like beta                                        
  **12154**                                       1.09                    -4                      Bmp10             Bone morphogenetic protein 10                             
  **17831**                                       1.02                    -40                     Muc2              Mucin 2                                                   **19**
  **17063**                                       0.91                    -60                     **Muc13**         Mucin 13, epithelial transmembrane                        
  **Transporter and binding activity**                                                                                                                                        
  **11773**                                       1.09                    -14.8                   Ap2m1             Adaptor protein complex AP-2, mu1                         
  **80718**                                       0.91                    -6.4                    Rab27b            RAB27b, member RAS oncogene family                        
  **56185**                                       1.00                    -19.2                   Hao3              Hydroxyacid oxidase (glycolate oxidase) 3                 
  **110052**                                      1.00                    -8.4                    Dek               DEK oncogene (DNA binding)                                **16**
  **12829**                                       0.98                    -10.8                   Col4a4            Procollagen, type IV, alpha 4                             
  **16467**                                       1.13                    -11.6                   Atcay             Ataxia, cerebellar, Cayman type homolog (human)           
  **13487**                                       0.95                    -20                     Slc26a3           Solute carrier family 26, member 3                        
  **216156**                                      0.92                    -4                      Wdr18             WD repeat domain 18                                       
  **69008**                                       1.23                    -6.4                    Cab39l            Calcium binding protein 39-like                           
  **12351**                                       0.84                    -4                      Car4              Carbonic anhydrase 4                                      
  **72832**                                       0.93                    -14.8                   Crtac1            Cartilage acidic protein 1                                
  **75600**                                       1.20                    -8                      Calml4            Calmodulin-like 4                                         
  **Apoptosis**                                                                                                                                                               
  **15874**                                       0.96                    -40                     Iapp              Islet amyloid polypeptide                                 
  **17831**                                       1.02                    -40                     Muc2              Mucin 2                                                   **19**
  **71361**                                       1.15                    -8                      Amid              Apoptosis-inducing factor, mitochondrion-associated 2     
  **16334**                                       0.98                    -40                     Ins2              Insulin II                                                
  **17063**                                       0.91                    -60                     **Muc13**         Mucin 13, epithelial transmembrane                        
  **Transcription activity**                                                                                                                                                  
  **109275**                                      0.94                    -4                      Actr5             ARP5 actin-related protein 5 homolog (yeast)              
  **71458**                                       0.89                    -6                      Bcor              Bcl6 interacting corepressor                              
  **14463**                                       1.01                                            Gata4             GATA binding protein 4                                    
  **Epigenetic and chromatin modification**                                                                                                                                   
  **213742**                                      1.00                    -8.8                    Xist              Inactive X specific transcripts                           
  **75796**                                       0.86                    -4                      Cdyl2             Chromodomain protein, Y chromosome-like 2                 
  **Inflammatory and immune response**                                                                                                                                        
  **21786**                                       0.90                    -10.8                   Tff3              Trefoil factor 3, intestinal                              
  **15101**                                       0.90                    -7.6                    H60               Histocompatibility 60                                     
  **94071**                                       1.00                    -4                      Clec2h            C-type lectin domain family 2, member h                   
  **Cell differentiation**                                                                                                                                                    
  **12154**                                       1.09                    -4                      Bmp10             Bone morphogenetic protein 10                             
  **14463**                                       1.01                    -8                      Gata4             GATA binding protein 4                                    
  **72324**                                       0.86                    -4                      Plxdc1            Plexin domain containing 1                                
  **20755**                                       1.31                    -16                     Sprr2a            Small proline-rich protein 2A                             
  **22268**                                       0.90                    -6                      Upk1b             Uroplakin 1B                                              
  **75770**                                       0.85                    -8.4                    Brsk2             BR serine/threonine kinase 2                              
  **Maintenance of cell polarity and shape**                                                                                                                                  
  **76499**                                       1.02                    -8.8                    Clasp2            CLIP associating protein 2                                
  **20755**                                       1.31                    -16                     Sprr2a            Small proline-rich protein 2A                             

**Ref**.\* = References identifying genes previously shown to have deregulated expression in pancreatic cancer

Selected genes (highlighted in Table [1](#T1){ref-type="table"}, [2](#T2){ref-type="table"} and [3](#T3){ref-type="table"}) from various functional categories were further verified by RT-PCR for their expression patterns (Fig. [2A](#F2){ref-type="fig"}). This selection was based on results in the literature indicating a direct or indirect role for each candidate gene in RNA processing, cell signaling, cell proliferation or apoptosis and cell adhesion and motility activities resulting in tumor growth and tumor progression. Many of these genes listed in Table [1](#T1){ref-type="table"}and [2](#T2){ref-type="table"}, such as Birc5, Brca1, Ccnb2, CXCR4, Mcm2, Mcm4, Mcm7, Nap1l1, Rad51, Sf3b, S100g \[[@B10]-[@B17]\]have been shown to be upregulated, while Cldn18, Muc2, Muc13, and b-myc \[[@B18]-[@B21]\]are shown to be down regulated in human pancreatic cancer as well as other types of cancer (please see Table [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}for their full names). However, strong expression of Muc13 in 50% of samples as well as b-*myc*in pancreatic cancer cells was unexpected and needs further characterization.

![**Selected genes showing up- or down regulation of mRNA expression by semi quantitative RT-PCR**. **A)**All selected genes showed expression pattern similar to microarray data upon confirmation by sqRT-PCR. A representative data from four Ela-*c-myc*pancreatic tumors, liver metastatic lesions and normal pancreas is presented. **B)**RT-PCR showing representative differentially expressed genes in liver metastatic lesions compared to primary pancreatic tumors and normal pancreas. **C)**Two genes, Igfbp1 and Serpina1a, were verified in human pancreatic cancer cell lines with high (High-met) and low metastatic (Low-met) potentials. Expression patterns of both genes were consistent with the murine microarray and RT-PCR data. **D)**RT-PCR was performed on RNA from primary pancreatic tumors (PT), liver metastatic lesions (LM) and normal pancreas (NP) with three overlapping primer sets spanning the region from exon 1 to 10. Primary pancreatic tumors showed presence of both wild type Wt1 and Wt1 variant without exon 5, while metastatic lesions either lacked expression or had low levels of Wt1 gene expression (showed a smaller size non-specific PCR product only).](1476-4598-7-11-2){#F2}

###### 

Upregulated genes in liver metastatic lesions. Relative fold change in liver metastatic lesions compared to primary pancreatic tumors (LM/PT) and in primary pancreatic tumors compared to normal pancreas (PT/NP)

  **Entrez Gene \#**                               **Fold change LM/PT**   **Fold change PT/NP**   **Gene Symbol**   **Gene description**                                           **Ref.\***
  ------------------------------------------------ ----------------------- ----------------------- ----------------- -------------------------------------------------------------- --------------
  **Transporter activity**                                                                                                                                                          
  **27413**                                        5.1                     0.6                     Abcb11            ATP-binding cassette, sub-family B (MDR/TAP), member 11        
  **12870**                                        11.8                    0.9                     Cp                Ceruloplasmin                                                  
  **107141**                                       4.2                     1.1                     Cyp2c37           Cytochrome P450, family 2. subfamily c, polypeptide 37         
  **76279**                                        9.1                     0.6                     Cyp2d26           Cytochrome P450, family 2. subfamily d, polypeptide 26         
  **13107**                                        7.8                     0.3                     Cyp2f2            Cytochrome P450, family 2, subfamily f, polypeptide 2          
  **14263**                                        11.3                    0.4                     Fmo5              Flavin containing monooxygenase 5                              
  **268756**                                       9.0                     0.5                     Gulo              Gulonolactone (L-) oxidase                                     
  **20493**                                        8.3                     0.3                     Slc10a1           Solute carrier family 10 member 1                              
  **69354**                                        8.3                     1.0                     Slc38a4           Solute carrier family 38, member 4                             
  **28253**                                        4.9                     0.9                     Slco1b2           Solute carrier organic anion transporter family, member 1b2    
  **Cellular metabolism**                                                                                                                                                           
  **67758**                                        10.6                    0.3                     Aadac             Arylacetamide deacetylase (esterase)                           
  **208665**                                       11.4                    0.3                     Akr1d1            Aldo-keto reductase family 1, member D1                        
  **11806**                                        43.3                    0.8                     Apoa1             Apolipoprotein A-I                                             
  **238055**                                       12.2                    0.6                     Apob              Apolipoprotein B                                               
  **12116**                                        33.0                    0.6                     Bhmt              Betaine-homocysteine methyltransferase                         
  **14121**                                        9.3                     0.7                     Fbp1              Fructose bisphosphatase 1                                      
  **227231**                                       33.6                    0.3                     Cps1              Carbamoyl-phosphate synthetase 1                               
  **231396**                                       14.8                    1.0                     Ugt2b36           UDP glucuronosyltransferase 2 family, polypeptide B36          
  **15233**                                        6.9                     0.4                     Hgd               Homogentisate 1, 2-dioxygenase                                 
  **15483**                                        4.2                     0.2                     Hsd11b1           Hydroxysteroid 11-beta dehydrogenase 1                         
  **13850**                                        7.8                     0.4                     Ephx2             Epoxide hydrolase 2, cytoplasmic                               
  **13077**                                        7.0                     0.8                     Cyp1a2            Cytochrome P450, family 1, subfamily a, polypeptide 2          
  **54150**                                        18.2                    0.5                     Rdh7              Retinol dehydrogenase 7                                        
  **72094**                                        7.4                     1.0                     Ugt2a3            UDP glucuronosyltransferase 2 family, polypeptide A3           
  **103149**                                       6.3                     0.6                     Upb1              Ureidopropionase, beta                                         
  **16922**                                        5.4                     0.4                     Phyh              Phytanoyl-CoA hydroxylase                                      
  **Calcium binding activity**                                                                                                                                                      
  **19733**                                        11.6                    0.5                     Rgn               Regucalcin                                                     
  **14067**                                        6.9                     0.5                     F5                Coagulation factor V                                           
  **16426**                                        48.0                    1.0                     Itih3             Inter-alpha trypsin inhibitor, heavy chain 3                   
  **Cell organization and biogenesis**                                                                                                                                              
  **11625**                                        40.5                    0.9                     Ahsg              Alpha-2-HS-glycoprotein                                        
  **19699**                                        5.5                     0.5                     Reln              Reelin                                                         
  **16008**                                        6.0                     1.0                     Igfbp2            Insulin-like growth factor binding protein 2                   
  **14080**                                        74.7                    1.0                     Fabp1             Fatty acid binding protein 1, liver                            
  **Protease Inhibitor activity**                                                                                                                                                   
  **20700**                                        24.9                    4.1                     **Serpina1a**     Serine (or cysteine) peptidase inhibitor, clade A, member 1a   **25, 51**
  **20702**                                        100.1                   0.4                     Serpina1c         Serine (or cysteine) peptidase inhibitor, clade A, member 1c   
  **59083**                                        22.8                    0.3                     Fetub             Fetuin beta                                                    
  **Inflammatory and Immune response**                                                                                                                                              
  **12628**                                        4.4                     1.1                     Cfh               Complement component factor h                                  
  **17175**                                        4.5                     1.0                     Masp2             Mannan-binding lectin serine peptidase 2                       
  **11625**                                        40.5                    0.9                     Ahsg              Alpha-2-HS-glycoprotein                                        
  **15439**                                        14.4                    7.6                     Hp                Haptoglobin                                                    
  **18405**                                        15.8                    1.4                     Orm1              Orosomucoid 1                                                  
  **12583**                                        8.4                     0.8                     Cdo1              Cysteine dioxygenase 1, cytosolic                              
  **13850**                                        7.8                     0.4                     Ephx2             Epoxide hydrolase 2, cytoplasmic                               
  **11699**                                        90.2                    0.2                     Ambp              Alpha 1 microglobulin/bikunin                                  **28**
  **Cell Adhesion**                                                                                                                                                                 
  **12558**                                        4.7                     1.0                     Cdh2              Cadherin 2                                                     
  **14067**                                        6.9                     0.5                     F5                Coagulation factor V                                           
  **16008**                                        6.0                     1.0                     Igfbp2            Insulin-like growth factor binding protein 2                   
  **19699**                                        5.5                     0.5                     Reln              Reelin                                                         
  **17175**                                        4.5                     1.0                     Masp2             Mannan-binding lectin serine peptidase 2                       
  **14080**                                        74.7                    1.0                     Fabp1             Fatty acid binding protein 1, liver                            
  **Cell growth and cell cycle**                                                                                                                                                    
  **14080**                                        74.7                    1.0                     Fabp1             Fatty acid binding protein 1, liver                            
  **16008**                                        6.0                     1.0                     Igfbp2            Insulin-like growth factor binding protein 2                   
  **11625**                                        40.5                    0.9                     Ahsg              Alpha-2-HS-glycoprotein                                        
  **Cell motility and migration**                                                                                                                                                   
  **12558**                                        4.7                     1.0                     Cdh2              Cadherin 2                                                     
  **19699**                                        5.5                     0.5                     Reln              Reelin                                                         
  **16841**                                        4.8                     0.6                     Lect2             Leukocyte cell-derived chemotaxin 2                            
  **20315**                                        4.5                     0.1                     Cxcl12            Chemokine (C-X-C motif) ligand 12                              
  **12738**                                        2.8                     0.3                     Cldn2             Claudin 2                                                      
  **Cell communication and Signal Transduction**                                                                                                                                    
  **208665**                                       11.4                    0.3                     Akr1d1            Aldo-keto reductase family 1, member D1                        
  **22139**                                        38.8                    0.1                     **Ttr**           Transthyretin                                                  
  **16008**                                        6.0                     1.0                     Igfbp2            Insulin-like growth factor binding protein 2                   
  **20526**                                        13.1                    0.3                     Slc2a2            Solute carrier family 2, member 2                              
  **238055**                                       12.2                    0.6                     Apob              Apolipoprotein B                                               
  **50765**                                        4.4                     0.7                     Trfr2             Transferrin receptor 2                                         
  **107146**                                       4.7                     0.7                     Glyat             Glycine-N-acyltransferase                                      
  **51811**                                        5.7                     0.7                     Clec4f            C-type lectin domain family 4, member f                        
  **14080**                                        74.7                    1.0                     Fabp1             Fatty acid binding protein 1, liver                            
  **56720**                                        4.0                     0.8                     Tdo2              Tryptophan 2,3-dioxygenase                                     
  **11625**                                        40.5                    0.9                     Ahsg              Alpha-2-HS-glycoprotein                                        
  **353283**                                       4.1                     42.0                    Eras              ES cell-expressed Ras                                          
  **19699**                                        5.5                     0.5                     Reln              Reelin                                                         
  **16006**                                        28.1                    0.7                     I**gfbp1**        Insulin-like growth factor binding protein 1                   **28,30,31**

**Ref**.\* = References identifying genes previously shown to have deregulated expression in pancreatic cancer

We evidenced notable changes in the family members of insulin-like growth factor (Igf). While Igf1 expression was slightly decreased in tumors compared with normal pancreas in the wild type littermates, Igf2 expression was dramatically increased (Fig [3A](#F3){ref-type="fig"}). All three receptors for Igf1 and Igf2 showed only slight increase in their expression, on the other hand all Igf binding proteins (Igfbp1, Igfbp2, Igfbp3, Igf2bp1 etc.) were downregulated compared to normal pancreas. Western blot analysis confirmed increased expression of cleaved, active form of Igf2 (Fig [3B](#F3){ref-type="fig"}).

![**Expression of IGF family genes and proteins**. **A)**Microarray data show that expression of Igf2 is about 10 fold higher in pancreatic tumors compared to liver metastatic lesions and normal pancreas from Ela-*myc*transgenic mice. While other IGF family proteins only showed modest change. **B)**Western blot analysis of Insulin like growth factors and their receptor proteins. Western blot was performed in cell lysates prepared from primary pancreatic tumors (PT), liver metastatic lesions (LM) from Ela-*c-myc*transgenic mice and normal pancreas (NP) from wild type littermates. Consistent with microarray data, PT samples showed noticeably higher protein levels compared to NP samples. A representative data from four PT and four NP samples are presented.](1476-4598-7-11-3){#F3}

Identification of potential metastasis promoting genes in c-*myc*induced pancreatic tumors
------------------------------------------------------------------------------------------

As mentioned above, we identified a small number of genes that were under various functional categories in metastatic tissues, which were either significantly upregulated or downregulated compared to PT. Interestingly, genes that were downregulated in liver metastatic lesions were comparatively much fewer than upregulated genes. Table [3](#T3){ref-type="table"} shows 4-fold higher and Table [4](#T4){ref-type="table"}, 4-fold lower expression levels in LM compared to PT. Most of the highly upregulated genes such as Cp, Apoa1, Ttr in liver metastatic lesions are known biomarkers for the detection of ovarian or other types of cancer \[[@B22]-[@B24]\]. Other highly upregulated genes were related to protease inhibition such as Serpina1a, Serpina1c, Ambp \[[@B25]-[@B27]\]and insulin growth factor binding proteins such as Igfbp1 and Ifgbp2 \[[@B28]-[@B31]\], which have been shown to be upregulated in human pancreatic cancer as well as in the animal models of either pancreatic cancer or other types of cancer. For the verification of some of these genes, we selected two upregulated and two downregulated genes, that showed striking differences from primary pancreatic tumors. In line with our mocroarray data, all LM samples verified by RT-PCR showed highly consistent results (Figure [2B](#F2){ref-type="fig"}).

###### 

Downregulated genes in liver metastatic lesions. Relative fold change in liver metastatic lesions compared to primary pancreatic tumors (LM/PT) and in primary pancreatic tumors compared to normal pancreas (PT/NP)

  **Entrez Gene \#**                               **LM/PT**   **PT/NP**   **Gene Symbol**   **Gene description**                                             **Ref.\***
  ------------------------------------------------ ----------- ----------- ----------------- ---------------------------------------------------------------- ------------
  **Cell communication and Signal transduction**                                                                                                              
  **22329**                                        0.5         23.5        Vcam1             Vascular cell adhesion molecule 1                                
  **58194**                                        0.4         4.0         Sh3kbp1           SH3-domain kinase binding protein 1                              
  **15186**                                        0.1         15.0        Hdc               Histidine decarboxylase                                          
  **11438**                                        0.2         4.9         Chrna4            Cholinergic receptor, nicotinic, alpha polypeptide 4             
  **12524**                                        0.6         4.6         Cd86              CD86 antigen                                                     
  **93761**                                        0.2         4.2         Smarca1           SWI/SNF related, regulator of chromatin, subfamily a, member 1   
  **Cell motility and migration**                                                                                                                             
  **12767**                                        0.7         4.7         **Cxcr4**         Chemokine (C-X-C motif) receptor 4                               **25**
  **17381**                                        2.8         7.6         **Mmp12**         Matrix metallopeptidase 12                                       **16**
  **11438**                                        0.2         4.9         Chrna4            Cholinergic receptor, nicotinic, alpha polypeptide 4             
  **Cell Adhesion**                                                                                                                                           
  **12505**                                        0.6         5.3         Cd44              CD44 antigen                                                     **11**
  **22329**                                        0.5         23.5        Vcam1             Vascular cell adhesion molecule 1                                
  **Cell death and apoptosis**                                                                                                                                
  **18616**                                        0.2         11.2        **Peg3**          Paternally expressed 3                                           
  **11801**                                        0.6         31.1        Cd5l              CD5 antigen-like                                                 
  **58194**                                        0.4         4.0         Sh3kbp1           SH3-domain kinase binding protein 1                              
  **Inflammatory and Immune response**                                                                                                                        
  **20210**                                        0.1         14.1        **Saa3**          Serum amyloid A 3                                                
  **58194**                                        0.4         4.0         Sh3kbp1           SH3-domain kinase binding protein 1                              
  **15186**                                        0.1         15.0        Hdc               Histidine decarboxylase                                          

**Ref**.\* = References identifying genes previously shown to have deregulated expression in pancreatic cancer

Decreased or lost expression of Wt1 mRNA in primary pancreatic tumors
---------------------------------------------------------------------

Wt1 is a transcription factor and has been found to be overexpressed in several types of cancers with poor prognosis. Our microarray data showed two-fold higher expression of the Wt1 gene in PT samples compared to NP samples. RT-PCR with a pair of primers that amplify exons 1 to 7 could detect Wt1 mRNA in PT but not in NP and LM (Fig. [2D](#F2){ref-type="fig"}). Interestingly, liver metastatic lesions expressed a lower molecular species of mRNA. We purified the higher band from primary tumors and the lower band from liver metastatic lesions and sequenced the PCR products. The results showed that the Wt1 mRNA in PT contained both wild type Wt1 and Wt1 variant without exon 5 (-51 nt). The slight difference in length could be visualized on agarose gel when the PCR products were separated further (Fig. [2D](#F2){ref-type="fig"}, amplified zone). On the other hand, sequencing results of the band in liver metastatic lesions showed that it was a product of Uroc1 (urocanase domain containing 1) gene, not Wt1. Comparison of the primer sequences with the mouse Uroc1 cDNA (NM_144940) showed high homology, and therefore a non-specific band (Uroc1) was amplified with this primer pair. Since human Uroc1 gene is highly expression in hepatoblastoma than in fetal liver \[[@B32]\], it is possible that Uroc1 is preferentially expressed in liver tumors and thus may serve as a marker. PCR with another pair of primers that amplified nt1444-1943 region of the mRNA also showed that LM expressed much lower levels of Wt1. Considering that a tissue is heterogeneous in cell types, it is reasonable to assume that the Wt1 mRNA detected in LM was derived from stromal tissue whereas the cancer cells might have lost Wt1 expression.

Real-time Quantitative Reverse Transcription-PCR Validation
-----------------------------------------------------------

To confirm the array gene expression data, we performed quantitative reverse transcription-PCR (qRT-PCR) for a selected set (n = 10) of genes and the representative data for three genes are shown in Table [4](#T4){ref-type="table"}. Although the extent of measured values detected by the two methods varied, an overall pattern concordance between qRT-PCR and Affymetrix cDNA array experiments was observed (i.e., same trend of induction or suppression was detected by both methods for each target genes). This difference may be due to probe design or the GeneChip system hybridization conditions. For all qRT-PCR, primers specific to β-actin were used as a control to normalize each experiment. Results are presented in Table [5](#T5){ref-type="table"}.

###### 

Quantitative RT-PCR. Relative quantity of mRNA expression in PT, LM and NP tissues measured by quantitative real time PCR

  -------------- -------------------------- --------- --------- --------- --------- --------- --------- ---------
                 **Relative fold change**                                                               
                                                                                                        
  **Genes**      **PT1**                    **LT1**   **PT2**   **LT2**   **PT3**   **LT3**   **NP1**   **NP2**
  **Igfbp1**     14.4                       70.0      2.0       20.0      10.0      90.0      2.0       2.0
  **Sepina1a**   16.9                       4.9       28.9      78.4      14.4      40.0      2.0       2.0
  **Peg3**       0.4                        0.2       4.9       10.0      16.0      8.1       2.0       2.0
  **β-actin**    1.0                        1.0       1.0       1.0       1.0       1.0       1.0       1.0
  -------------- -------------------------- --------- --------- --------- --------- --------- --------- ---------

Verification of microarray data in human pancreatic cancer cell lines
---------------------------------------------------------------------

A panel of human pancreatic cancer cell lines that were reportedly to have high or low metastatic potential in immunodeficient mouse models were used to verify the data from Ela-*c-myc*model of primary and metastatic pancreatic tumors. Cell lines with high metastatic potential include PANC28, CoLo357fg, L3.6pl and low- or non-metastatic potential include PANC1 and BxPC3. We verified two genes in human cell lines, Igfbp1 and Serpina1a, these genes were highly upregulated in liver metastaic tissues compared to primary pancreatic tumors from transgenic mice. Expression patterns of both genes were consistent with the murine microarray and RT-PCR data (Fig. [2C](#F2){ref-type="fig"}).

Discussion
==========

In this study, we report the genome-wide expression profiles of primary pancreatic tumors and liver metastatic lesions from Ela-*c-myc*transgenic mice, or normal pancreas from wild-type mice. cDNA microarray analysis showed several gene clusters under various functional categories in primary or metastatic pancreatic tumors of Ela-*c-myc*transgenic mice that differ from normal pancreas of non-transgenic littermates. Notably, increased expression was observed for a large number of genes related to ribosomal biogenesis, maturation and ribosome assembly in primary or metastatic pancreatic tumors. Previous studies by others have also shown enhanced expression of genes related to ribosomal proteins, rRNA maturation and ribosome assembly, in addition to enhanced expression of many translation initiation and elongation factors in c-Myc overexpressing cells \[[@B33]-[@B35]\]. Thus, our model recapitulates the experimental observations and key features of c-Myc overexpressing tumors.

Genes involved in posttranscriptional regulation was a major functional category of upregulated genes in both PT and LM compared to NP samples, we observed changes in expression for splicing factors, RNA binding/pre-mRNA processing factors and spliceosome related genes, indicating that events related to RNA processing may play critical roles in pancreatic tumor development and progression induced by c-Myc. More than 50% of human genes undergo alternative splicing, and this type of RNA process has recently become an emerging topic in molecular and clinical oncology \[[@B36]-[@B38]\]. Our data showed upregulation of several splicing factors from the SR family such as Sfrs1, Sfrs2, Sfrs3, Sf3b in both primary and metastatic tumors compared to normal pancreas. SR proteins represent a family of essential splicing factors, which are characterized by extensively phosphorylated serine-arginine rich domains \[[@B39]\]. SR proteins recognize splice sites and, depending on their relative levels, these proteins can influence alternative RNA processing \[[@B40]\].

Other groups of genes that were upregulated are involved in DNA replication, cell proliferation and cell cycle regulation; chromosome organization and biogenesis; and signal transduction. Many genes are related to the maintenance of chromosomal structure and integrity such as minichromosome maintenance (Mcm)2, Mcm5, Mcm10, structural maintenance of chromosome (Smc)2l1, Smc4l1, Smc5l1, Rad51, Brca1 and Centromere component (Cenp-I). The entire Mcm protein family (Mcm2-7) is essential in regulating the replication of DNA. Amplification of genes in the Mcm family has been detected in various cancer cells \[[@B41]\]. Their upregulation may deregulate the complete and accurate DNA replication and thus result in failure to maintain the genetic integrity of affected cells. Smc family proteins are integral components of the machinery that modulates chromosome structure for mitosis \[[@B42]\]. Similarly, Rad51, brca1 and Cenp-I play a role in maintenance of genetic integrity \[[@B43],[@B44]\]. We also noticed increased expression of some X-linked genes related to signal transduction such as Rsk4, Dusp9 and S100g, which have not been reported previously in pancreatic tumors.

Intriguingly, we observed highly upregulated expression of Igfbp1 and Serpina1 in liver metastatic tissues compared to primary pancreatic tumors and normal pancreas. Verification of Igfbp1 and Serpina1 by RT-PCR and quantitative PCR showed strong expression in liver metastatic lesions but there was a lack of expression of these genes in primary pancreatic tumors or normal pancreas. Similarly, both these genes also showed higher expression in highly metastatic human pancreatic cell lines (PANC28, CoLo357fg, L3.6pl) and lower expression levels in less-metastatic cell lines (PANC1 and BxPC3). Several studies have described the inhibitory and potentiating activities of both Serpina1 and Igfbp1 in a variety of cells \[[@B45]-[@B47]\]. Igfbp1 interacts with α~5~β~1~integrin, influencing cell adhesion and migration. Jones *et al*. \[[@B48]\] first reported the increased migration of Chinese hamster ovary cells transfected to express human Igfbp1. Increased expression of several Igfbps has also been reported in human pancreatic cancer \[[@B28]-[@B31]\]. Serpins are endogenous inhibitors of serine protease activity *in vivo*\[[@B49],[@B50]\] and a large number of studies support the notion that proteases play an important role in the progression of malignant tumors. Therefore, the expression of proteinase inhibitors is considered to be an anti-malignant event. Serpina1, a major inhibitor of human serine proteases in serum, is produced mainly by the liver, but also by extra-hepatic cells, including neutrophils and certain cancer cells \[[@B51],[@B52]\]. However, clinical studies have shown that high circulating levels of Serpina1 directly correlate with tumor progression \[[@B53],[@B54]\]. Immunohistochemical studies revealed that patients with Serpina1-positive lung adenocarcinomas had a worse prognosis than Serpina1-negative ones \[[@B55]\]. More interestingly, both Serpina1 and Igfbp1 have been demonstrated to play a role in human invasive and metastatic pancreatic cancer. Together these studies and our findings suggest that Igfbp1 and Serpina1 may play critical roles in tumor progression *in vivo*, and are potential candidates for therapeutic interventions.

We also compared our gene expression profiles with published data on human pancreatic cancer tissues or cell lines. Gene expression pattern of many genes such as Serpina1, Igfbp1, Wt1, CD44, MMP12, CXCR4, Muc2, Dek, Capza1, Bcra1, Birc5, S100g, Claudin-18, RAD51, Mcm2, Mcm4, Mcm7, Cyclin B2, splicing factor 3b, Nap1l1 etc. (please see Tables [1](#T1){ref-type="table"}, [2](#T2){ref-type="table"}, [3](#T3){ref-type="table"} and [4](#T4){ref-type="table"}for references) was similarly reported in other studies and therefore provide a validation for our model.

Conclusion
==========

We show differential gene expression profiles under several functional categories in normal pancreas, primary pancreatic tumors and liver metastases. We identified two genes, Igfbp1 and Serpina1, which were overexpressed only in liver metastatic lesions suggesting that these genes are likely to be involved in the establishment of metastases in Ela-myc transgenic animal model. In addition, metastatic lesions appear to have low levels or absence of Wt1 gene expression while primary tumors express at least two major variants (+ exon 5 or - exon 5) Wt1 transcripts. Igfbp1 and Serpina1 may serve as clinically interesting biomarkers are likely to be useful for prognostic or therapeutic purposes in metastatic pancreatic cancer.

Methods
=======

Ela-*myc*transgenic mice
------------------------

We used Ela-*myc*transgenic mice with a FVB background, this strain was generated by crossbreeding of C57BL/6xSJL background Ela-*myc*\[[@B5]\] mice (obtained from Dr. Sandgren at the University of Wisconsin) with a FVB strain. The F1 mice were crossed together to generate F2 transgenic mice and some of the F2 mice were crossed to yield F3 mice. The F2 and F3 transgenic mice and their wild type littermates were used in this study.

Human Pancreatic cancer cell lines
----------------------------------

A panel of human pancreatic cell lines, PANC1, PANC-28, CoLo357, L3.6pl and BxPC3, were used to verify the microarray data. All pancreatic cell lines were cultured in RPMI 1640 supplemented with 10% fetal bovine serum, penicillin and streptomycin. Cells were harvested when they were about 80--90% confluent for RNA isolation.

cDNA microarray
---------------

Primary pancreatic cancer tissue, its corresponding liver metastatic lesion and normal pancreatic tissues were used to prepare RNA using the RNeasy mini kit (Qiagen) per manufacturer\'s instructions. Assurance of quality assessment and microarray analysis were carried out by personnel in the Applied Genomics Technology Center (Center for Molecular Medicine and Genetics, Wayne State University). Briefly, biotin-labeled RNA fragments were produced from 1 μg of RNA by first synthesizing double-stranded cDNA followed by *in vitro*transcription and fragmentation reactions. A hybridization cocktail, containing the fragmented cRNA, probe array controls, bovine serum albumin, and herring sperm DNA, was prepared and hybridized at 45°C for 16 h to the High Density Mouse Genome M430-2 containing 45101 probesets (Affymetrix Inc., Santa Clara, CA). The hybridized probe array was washed, and bound biotin-labeled cRNA was detected with streptavidin-phycoerythrin conjugate. Each probe array was scanned twice (Hewlett-Packard GeneArray Scanner), the images were overlaid, and the average intensities of each probe cell were compiled. Microarray was repeated three times for each condition (LM, PT, NP).

cDNA microarray data analysis
-----------------------------

High density microarray image files were interpreted and quality assessed to Affymetrix standards in GCOS 1.1 as described previously \[[@B56]\]. Expression changes were filtered in DChip for fold change (\> 4 fold) between the experiments. Hierarchical clustering was carried out using Dchip and ontological analysis of gene expression was conducted in both OntoExpress in conjunction with curated pathway analysis using the KEGG Biocarta and GeneGo systems. At least three samples from each condition were used for Affymetrix microarray analysis to select candidate genes. Candidate genes were also confirmed with semi-quantitative, quantitative RT-PCR analysis and/or western blot at least 3 times.

Semiquantitative RT-PCR
-----------------------

Total RNA, isolated from the primary or metastatic lesions and normal pancreas of Ela-*c-myc*transgenic mice, was subjected to first-strand cDNA synthesis using an oligo (dT) primer and Moloney murine leukemia virus (MMLV) reverse transcriptase (Invitrogen). The primer amplified products were separated on ethidium bromide containing 1.2% agarose gels. Primers for the semiquantitative and quantitative detection of target mRNAs are presented in Table [6](#T6){ref-type="table"}.

###### 

List of primer. Primer sets for qRT-PCR and sqRT-PCR

  **Gene name**          **Accession No**.   **Quantitative or sqRT-PCR primer sequence**
  ---------------------- ------------------- ----------------------------------------------
  **CXCR4**                                  
  Upstream               D87747              CATGGAACCGATCAGTGTGA (325)\*
  Downstream                                 TTTCCCAAAGTACCAGTCAGC
  **MMP2**                                   
  Upstream               NM_008610           CTGTGTTCTTCGCAGGGAAT (433)
  Downstream                                 TGTGCAGCGATGAAGATGAT
  **Snail2**                                 
  Upstream               NM_011415           TTCCTCTGACACTTCATCCAA (474)
  Downstream                                 TTGGAGCAGTTTTTGCACTG
  **E-tcad**                                 
  Upstream               NM_009864           CCTGCCAATCCTGATGAAAT (329)
  Downstream                                 TCAGGGA AGGAGCTGAAAGA
  **Fgf13**                                  
  Upstream               AF020737            CATTTTCTGCCCAAACCACT (378)
  Downstream                                 AATGCTTGGCACTCTTTTGC
  **Rsk4**                                   
  Upstream               BB402211            GTGGGTGCCAAAGTTTTGAT (351)
  Downstream                                 CAAACCACATGGAAATCAGG
  **MIF**                                    
  Upstream               NM_010798.1         ACTACAGTAAGCTGCTGTGTGG (208)
  Downstream                                 ATCGCTACCGGTGGATAAAC
  **Mcm7**                                   
  Upstream               NM_008568.1         ACCGCGAAGTCAGTACACAA (208)
  Downstream                                 GATGGTCTGCTGCTCCATAA
  **Ttr**                                    
  Upstream               NM_013697.1         TGGAAGACACTTGGCATTTC (194)
  Downstream                                 TGCTACTGCTTTGGCAAGAT
  **H2Aa**                                   
  Upstream               NM_010378.2         CCTTCATCCCTTCTGACGAT (197)
  Downstream                                 CAGGCCTTGAATGATGAAGA
  **Mrpl19**                                 
  Upstream               NM_026490.2         TGCATCCCATGAAGAAGAGA (183)
  Downstream                                 GACATTTGCTCGTTACAAAAGC
  **Dusp9**                                  
  Upstream               NM_029352.3         CCTGTGCTTGAGCTCTGATT (181)
  Downstream                                 GCTCTCCAAATTGGCTGAAT
  **S100g**                                  
  Upstream               NM_009789.2         CAGCAAAATGTGTGCTGAGA (197)
  Downstream                                 CTCCATCGCCATTCTTATCC
  **Serpina1a**                              
  Upstream               NM_009243           GCCCTGGCAAATTACATTCT (196)
  Downstream                                 CATTGCCTGCATAATCCATC
  **Peg3**                                   
  Upstream               NM_008817.2         ACCATTCAGGCCTCAGTTTC (205)
  Downstream                                 TTTTCTCAAATTCGCTGACG
  **Igfbp1**                                 
  Upstream               NM_008341           CCTGCCAACGAGAACTCTAT (196)
  Downstream                                 GGGATTTTCTTTCCACTCCA
  **Saa3**                                   
  Upstream               NM_011315.3         GCGAGCCTACTCTGACATGA (196)
  Downstream                                 ATTGGCAAACTGGTCAGCTC
  **Cldn18**                                 
  Upstream               NM_019815.2         GCTGTACGAGCCCTGATGAT (193)
  Downstream                                 TGTTGGCAAACACAGACACA
  **Sfrs1**                                  
  Upstream               NM_173374.3         CACTGGTGTCGTGGAGTTTG (190)
  Downstream                                 CTTCTGCTACGGCTTCTGCT
  **Sfrs2**                                  
  Upstream               NM_013663.3         GCTTTGCTTTCGTCGAATTT (188)
  Downstream                                 AGGACTCCTCCTGCGGTAAT
  **Eif2**                                   
  Upstream               NM_026030.2         GGAGTTGCTGAACCGAGTGT (180)
  Downstream                                 AGGAGATGTTTGGGTTGACG
  **Muc13**                                  
  Upstream               NM_010739.1         TGCGTGATGCTACAAAGGAC (195)
  Downstream                                 TGTCCTGGCATTTACTGCTG
  **Igfbp1 (human)**                         
  Upstream               NM_000596.2         AAGGCACAGGAGACATCAGG (195)
  Downstream                                 TATCTGGCAGTTGGGGTCTC
  **Serpina1 (human)**                       
  Upstream               NM_001002235.1      TGCCTGATGAGGGGAAACTA (186)
  Downstream                                 CCCCATTGCTGAAGACCTTA
  **WT1(362--970)**                          
  Upstream               NC_000068           TCCAGCAGCCGGAGCAACCT (608)
  Downstream                                 AGGGCGTGTGGCCATAGCTG
  **WT1(947--1470)**                         
  Upstream               NC_000068           CGCCCAGCTATGGCCACACG (523)
  Downstream                                 ATTGCAGCCTGGGTATGCAC
  **WT1(1444--1943)**                        
  Upstream               NC_000068           TTCATGTGTGCATACCCAGG (499)
  Downstream                                 GTAGATCCACAGTCGTGTCC

\*PCR product size

Real-Time RT-PCR
----------------

cDNA from the primary or metastatic lesions Ela-*c-myc*transgenic and normal pancreas of wild type mice were subjected to PCR amplification, a maximum of 2 μl of each cDNA sample was used per 25-μl PCR reactions. The real-time measurements were analyzed in triplicate using an automated Real Time Cycler as described previously \[[@B56]\]. The relative quantity in primary tumor versus normal tissue or primary tumor versus metastatic lesion was normalized to β-actin.

Sequencing of Wilm\'s tumor suppressor gene (Wt1)
-------------------------------------------------

RT-PCR analysis using primers amplified nt947-1470 region of mouse Wt1 mRNA, which covers the first 7 exons, showed that liver metastases (but not primary pancreatic tumors) contained a lower molecular weight mRNA species. To verify the identity of the PCR products of the higher bands in primary tumor and lower band in liver metastatic lesions, we sequenced these bands using forward primer-947 after purifying them from agarose gels using Gel Extraction Kit (QIAEX II) from Qiagen.
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